Publications by authors named "John Pollack"

Claim this Profile
L
Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
Thomas A Ciulla, Rehan M Hussain, Donna Taraborelli, John S Pollack, David F Williams

Ophthalmol Retina· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes.
Thomas Ciulla, John S Pollack, David F Williams

Br J Ophthalmol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes.
Thomas A Ciulla, John S Pollack, David F Williams

Br J Ophthalmol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report From a US Food and Drug Administration-Cosponsored Forum.
Frank Brodie, Michael Repka, Stephen Allan Burns, S Grace Prakalapakorn, Christie Morse, John S Pollack

JAMA Ophthalmol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Visual Acuity at Wet AMD Diagnosis Predicts Long-Term Vision Outcomes: An Analysis of the IRIS Registry.
Allen C Ho, David M Kleinman, Flora C Lum, Jeffrey S Heier, Richard L Lindstrom, John S Pollack

Ophthalmic Surg Lasers Imaging Retina· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes.
Thomas A Ciulla, Rehan M Hussain, John S Pollack, David F Williams

Ophthalmol Retina· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small gauge vitrectomy: operative techniques.
John S Pollack, Naryan Sabherwal

Curr Opin Ophthalmol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States.
Thomas A Ciulla, Peter Bracha, John Pollack, David F Williams

Ophthalmol Retina· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
Jeffrey S Heier, Neil M Bressler, Robert L Avery, Sophie J Bakri, David S Boyer, John S Pollack

JAMA Ophthalmol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the Number of Outpatients Receiving Spiritual Assessment: A Pain and Palliative Care Service Quality Improvement Project.
Blanca J Gomez-Castillo, Rosemarie Hirsch, Hunter Groninger, Karen Baker, M Jennifer Cheng, John Pollack

J Pain Symptom Manage· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The valuable contribution of spiritual care to end-of-life care in the ICU*.
Marion Danis, John M Pollack

Crit Care Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of healthcare data in ophthalmology.
Nicholas G Anderson, John Pollack, David Williams

Curr Opin Ophthalmol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nature of life-transforming changes among cancer survivors.
Perry Skeath, Shanti Norris, Vani Katheria, Jonathan White, Karen Baker, John Pollack

Qual Health Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of topical anesthetics for intravitreal injections : a randomized clinical trial.
Michael J Davis, John S Pollack, Susan Shott

Retina· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyes.
Allen Chiang, Richard S Kaiser, Robert L Avery, Pravin U Dugel, Dean Eliott, John S Pollack

Retina· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Quan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, Roomasa Channa, Elham Hatef, John S Pollack

Ophthalmology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Microsurgical Safety Task Force: evolving guidelines for minimizing the risk of endophthalmitis associated with microincisional vitrectomy surgery.
Richard S Kaiser, Jonathan Prenner, Ingrid U Scott, Alexander J Brucker, Harry W Flynn, John Pollack

Retina· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
David R Fintak, Gaurav K Shah, Kevin J Blinder, Carl D Regillo, John Pollack

Retina· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term outcomes of 23-gauge pars plana vitrectomy.
Omesh P Gupta, Allen C Ho, Peter K Kaiser, Carl D Regillo, Sanford Chen, John S Pollack

Am J Ophthalmol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitrectomy for a symptomatic lamellar macular hole.
Bruce R Garretson, John S Pollack, Alan J Ruby, Kimberly A Drenser, George A Williams

Ophthalmology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
Judy E Kim, John S Pollack, David G Miller, Robert A Mittra, Richard F Spaide

Retina· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis.
John S Pollack, Douglas J Beecher, Jose S Pulido, Amy C Lee Wong

Curr Eye Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa.
Alan Y Chow, Vincent Y Chow, Kirk H Packo, John S Pollack, Gholam A Peyman

Arch Ophthalmol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is coxsackievirus the cause of unilateral acute idiopathic maculopathy?
Adam P Beck, Lee M Jampol, David A Glaser, John S Pollack

Arch Ophthalmol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of central serous chorioretinopathy in women.
Stephen L Perkins, Judy E Kim, John S Pollack, Pauline T Merrill

Ophthalmology· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis